A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma.
Saved in:
| Title: | A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma. |
|---|---|
| Authors: | Hu, Lina1,2 (AUTHOR), Lu, Bo3 (AUTHOR), Wei, Xiaolei4 (AUTHOR), Wang, Ying5 (AUTHOR), Xie, Mian6 (AUTHOR), Li, Jun1 (AUTHOR), Feng, Chun1 (AUTHOR), Li, Guoqiang1 (AUTHOR), Qiu, Xiao1 (AUTHOR), Zhang, Jiahe1 (AUTHOR), Guo, Xutao4 (AUTHOR), Zhong, Zhiren2 (AUTHOR), Li, Xiaoqing7 (AUTHOR) 18620385718@163.com, Zhang, Qian8 (AUTHOR) herpes@126.com, Zhou, Jihao1 (AUTHOR) zhoujihao@aliyun.com |
| Source: | Leukemia & Lymphoma. Jul2026, Vol. 67 Issue 8, p1707-1714. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
